M&T Bank
XERS icon

M&T Bank’s Xeris Biopharma Holdings XERS Stock Holding History

M&T Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-33,440
Closed -$136K – 1637
2021
Q2 		$136K Hold
33,440
– – ﹤0.01% 1500
2021
Q1 		$151K Hold
33,440
– – ﹤0.01% 1447
2020
Q4 		$165K Hold
33,440
– – ﹤0.01% 1551
2020
Q3 		$198K Buy
33,440
+7,404
+28% +$29.6K ﹤0.01% 1427
2020
Q2 		$69K Hold
26,036
– – ﹤0.01% 1478
2020
Q1 		$51K Buy
26,036
+5,493
+27% +$23.6K ﹤0.01% 1470
2019
Q4 		$145K Buy
20,543
+3,540
+21% +$29.2K ﹤0.01% 1300
2019
Q3 		$167K Buy
17,003
+2,262
+15% +$25.4K ﹤0.01% 1463
2019
Q2 		$169K Hold
14,741
– – ﹤0.01% 1451
2019
Q1 		$148K Buy
+14,741
New +$189K ﹤0.01% 1449

Other funds holding XERS

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

M&T Bank's XERS Position: Q3 2021 in Review

M&T Bank sold out of Xeris Biopharma Holdings (XERS) in Q3 2021, closing a stake of 33,440 shares — an estimated $136K sold.

M&T Bank first reported a position in XERS in Q1 2019 and held it in 10 quarters. The position peaked at $198K in Q3 2020. 70 funds tracked by Wall St. Rank hold XERS as of Q3 2021.

  • M&T Bank reported no remaining Xeris Biopharma Holdings position as of Q3 2021 after selling out during the quarter.
  • M&T Bank sold 33,440 Xeris Biopharma Holdings shares in Q3 2021, an estimated $136K.
  • M&T Bank first reported a position in Xeris Biopharma Holdings in Q1 2019 and held it in 10 quarters.
  • M&T Bank's Xeris Biopharma Holdings position peaked at $198K in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2021.

Based on M&T Bank's 13F filing for Q3 2021, filed 28 Oct 2021.